GlassScriptPhysician profile
Ruchika Goel
NPI 1912160151
$109,569.38
in general payments reported to CMS, 2019-2025
9 companies · $9,891 in 2025
The $9,891 reported for 2025 was more than what 85% of Pediatric Hematology-Oncology providers received nationally (typical 2025 total: $207).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59K · 2020: $25K · 2021: $11K · 2022: $4,714 · 2023: $208 · 2024: $267 · 2025: $9,891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,728 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,500 · Food and Beverage: $810 · Travel and Lodging: $284 · Education: $43.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,728.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,500.00 |
| Food and Beverage | $809.97 |
| Travel and Lodging | $284.20 |
| Education | $43.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rigel Pharmaceuticals, INC. | $51,880.46 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $41,809.29 | 2019-2023 | Ultomiris |
| Genzyme Corporation | $7,407.80 | 2024-2025 | |
| Terumo Bct, INC. | $5,406.97 | 2021-2024 | Reveos Automated Blood Processing System |
| Abbott Laboratories | $2,855.91 | 2023-2025 | Alinity |
| Astrazeneca Pharmaceuticals LP | $130.75 | 2022-2025 | Enhertu |
| Pfizer INC. | $58.30 | 2019 | |
| Ortho-Clinical Diagnostics, INC. | $19.90 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruchika Goel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.